Rare diseases
Investigational molecules
Locations
Back to France1 508 clinical trials in Quint-Fonsegrives, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Phase 1/2 study of AVZO-023 drug combination in patients with advanced cancer
FrancePhase 1b study of empasiprubart in adults with multifocal motor neuropathy to assess nerve morphology by ultrasound
FranceStudy of Baricitinib and Sirolimus to Maintain HIV Infection Control After Antiretroviral Treatment Interruption in Adults
FranceStudy of quizartinib‑based drug combination on measurable residual disease in adults 18‑60 with acute myeloid leukemia
FranceA Phase 3 Study of ASP2138 Plus Drug Combination in Adults with HER2‑Negative, CLDN18.2‑Positive Advanced Gastric Cancer (First‑Line Treatment)
FranceEffect of Continuing Tacrolimus on Access to a Second Kidney Transplant in Patients with Renal Transplant Failure: A Randomized Controlled Trial
FrancePegcetacoplan to Prevent Recurrence of C3 Glomerulopathy or Primary Immune‑Complex MPGN in Adolescent and Adult Kidney Transplant Recipients
FranceEfficacy of fluoxetine added to standard anti‑seizure therapy in children aged 8 years and older with drug‑resistant complex and rare epilepsy
FranceEffect of Continuing vs Stopping Dapagliflozin (with other drug combinations) on 30‑Day Cardiovascular Outcomes in Heart Failure Patients Undergoing Cardiac Surgery
FranceEvaluating mezagitamab in adults with late antibody-mediated rejection after kidney transplant
FranceA Randomized, Double‑Blind, Placebo‑Controlled Study of Momelotinib Dihydrochloride Monohydrate in Patients with VEXAS Syndrome
FranceAssessing the efficacy and safety of nemolizumab in patients aged 12 years or older with dystrophic epidermolysis bullosa
FranceThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on bladder cancer treatments, including innovative therapies for both muscle-invasive and non-muscle-invasive cases. Studies also address prostate conditions, from benign hyperplasia to advanced cancer.
Novel approaches combine immunotherapy with targeted treatments to improve patient outcomes.
Comprehensive research into breast cancer treatments, particularly focusing on triple-negative and hormone receptor-positive variants. Studies evaluate new approaches in colon cancer management using circulating tumor DNA analysis.
Investigations combine immunotherapy with traditional treatments for enhanced efficacy.
Research addressing pulmonary conditions and specialized medical needs. Studies include evaluation of treatments for chronic obstructive pulmonary disease and migraine management in emergency settings.
Focus on improving patient quality of life through innovative therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
